Interleukin-1 antagonism: a sturdy companion for immune tolerance induction in type 1 diabetes?
Immuno-endocrinology Laboratory, Section for Endocrinological Research, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; and Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden tmpo@sund.ku.dk.
Thomas
T
Mandrup-Poulsen
D000818:Animals; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000276:immunology*; D005968:Glutamate Decarboxylase / Q000235:genetics*; D053583:Interleukin-1beta / Q000276:immunology*; D007515:Islets of Langerhans / Q000276:immunology*; D019444:Vaccines, DNA / Q000494:pharmacology*
D053583:Interleukin-1beta; D019444:Vaccines, DNA; D005968:Glutamate Decarboxylase; C401141:glutamate decarboxylase 2